Download your free eBook to learn how Genentech can maximize the impact of its patient outreach strategies through AI and patient-level intent data with AllazoHealth.
Download Your Free eBook Now
Do you need to create the best patient experience for your strategic growth brands such as Ocrevus, Hemlibra, and Vabysmo, all while also maximizing every new patient start for your more mature brands? The answer? Boosting your patient engagement. Learn how to go beyond traditional personas or segmentation in today’s New Healthcare Economy with AllazoHealth.
Download this complimentary eBook from us to discover how you can more effectively predict, personalize, and maximize your marketing and engagement strategies:
- Learn how The New Healthcare Economy is redefining everything from patient acquisition to therapy initiation and adherence, and what that could mean for Genentech
- Discover how pharma marketers are realizing their omni-channel marketing objectives with AI-driven predictive analytics and personalization at the individual patient level
- See firsthand how a leading pharmaceutical company leveraged AI to boost first fill rates by nearly 10% and increase its patients’ length of therapy by nearly 15%
Fill out the form to receive your eBook
Related resources
Pharma Marketers Need AI Now Podcast
February 22, 2023 | William Grambley
With AI, pharma marketers can truly personalize campaigns, increase therapy initiation and medication adherence, and deliver efficiency at scale. For more, listen to this Pharma Marketing podcast.
Listen to podcast
[The AllazoHealth AI predicts] customers in our database who haven’t picked up the drug – they’re not considered patients yet. We run AI to analyze the behavior of these people. Would they react if we sent them a “touchpoint” via SMS, phone call, or email? Also at what time of day would they like to receive information? What’s the content they’d like to receive? AI figures out the right combination of those factors.
Sanofi
We chose AllazoHealth because of the predictive analytics. Most solution providers used market segmentation techniques which created hundreds of different patient groupings that was really specific to marketing outreaches and campaigns for engagement. While the groups may have shared similar behaviors and socioeconomic factors – what we wanted was the individual needs of the patient and their risks so that we could coach each patient individually based on their own set of needs. After evaluating several solution variations, we moved forward with AllazoHealth as a partner because their solution could provide us with a proactive approach to patient management and ultimately improving their health outcomes through treatment adherence. Through validation we found the solution set reliable with high repeatability. Our programs now create greater value for our manufacturer partners but more importantly greater impact to the patients we serve every day.
AmerisourceBergen
[AllazoHealth] provides a unique service that no one else offers. I could tell that the team cared about our challenges and wanted to do whatever they could to help, even working with our budget and looking for ways they could streamline the process to help us out.
Janssen